Changes in Hydroxyurea Use Among Youths Enrolled in Medicaid With Sickle Cell Anemia After 2014 Revision of Clinical Guidelines

IMPORTANCE: Youths with sickle cell anemia (SCA) are at risk of pain crises, stroke, and early death. Complications can be reduced by the oral disease-modifying medication hydroxyurea, and in 2014, the National Heart, Lung, and Blood Institute published revised guidelines that hydroxyurea should be...

Descripción completa

Detalles Bibliográficos
Autores principales: Reeves, Sarah L., Peng, Hannah K., Wing, Jeffrey J., Cogan, Lindsay W., Goel, Alka, Anders, David, Green, Nancy S., Lisabeth, Lynda D., Dombkowski, Kevin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313146/
https://www.ncbi.nlm.nih.gov/pubmed/36961463
http://dx.doi.org/10.1001/jamanetworkopen.2023.4584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313146/
https://www.ncbi.nlm.nih.gov/pubmed/36961463
http://dx.doi.org/10.1001/jamanetworkopen.2023.4584

Ejemplares similares